University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Office of Research Compliance

Kimberly Murphy

Maryland man receives first successful pig-to-human heart transplant

A Maryland man became the first person to receive a successful pig-to-human heart transplant. David Bennett, 57, is “still doing well” three days after the first-of-its-kind surgery, and will continue to be monitored to determine whether the transplant, conducted at the University of Maryland, provides lifesaving benefits, the university said in a statement. “This was a […]

Harvard University Professor Convicted of Making False Statements and Tax Offenses

Dr. Charles Lieber found guilty of concealing his affiliation with the Wuhan University of Technology and his participation in China’s Thousand Talents Program BOSTON – The former Chair of Harvard University’s Chemistry and Chemical Biology Department was convicted by a federal jury today in connection with lying to federal authorities about his affiliation with People’s Republic […]

Lack of Biobank Authorization Leads to Retraction of W. Virginia Paper

“A friendly word of caution to the research community—with the rise of biobanks/large datasets in the 21st century, researchers should pay particular attention to data rights restrictions and carefully vet the use of any data source before using it for scientific purposes.” Those words of advice came from a research team at the University of […]

Study coordinator charged in scheme to falsify clinical trial data

“According to court documents, Jessica Palacio, 34, of Miami, worked as a study coordinator at a clinical trial firm in Miami called Unlimited Medical Research….The indictment alleges that Palacio participated in a scheme to falsify medical records to make it appear as though pediatric subjects made scheduled visits to Unlimited Medical Research, received physical exams […]

FDA Threatens First Firm With Fines for Reporting Failure

After issuing a warning letter nearly a year ago for failure to post required summary trial results on ClinicalTrials.gov, the Food and Drug Administration (FDA) has given Cambridge, Massachusetts-based Acceleron Pharma Inc. a month to submit data from a Phase 2 trial of medications for the treatment of advanced renal cancer or it will face […]

Severe Sanctions Accompany ORI’s First Misconduct Finding of 2021

A former post-doctoral fellow at the McGovern Medical School, part of the University of Texas (UT) Health Science Center, admitted to committing research misconduct by “knowingly and intentionally falsifying, fabricating, and plagiarizing data and text” in six papers and eight manuscripts, according to the HHS Office of Research Integrity (ORI). In its Feb. 4 Federal […]

Former UF Researcher Indicted for NIH Fraud ‘Scheme’

Lin Yang, a former University of Florida (UF) researcher, has been indicted on six counts of wire fraud and four counts of making false statements, the Department of Justice (DOJ) announced Feb. 3. A grand jury returned the indictment on Dec. 15 related to an award of $1.75 million for which Yang was the principal […]

Florida Resident Pleads Guilty to Conspiracy to Falsify Clinical Trial Data

A Miami resident is facing up to 20 years in prison after pleading guilty to fabricating results for a GlaxoSmithKline-funded study of asthma medication for pediatric patients. Lisett Raventos, 46, of Miami, Florida, pleaded guilty today in the U.S. District Court for the Southern District of Florida today to one count of conspiracy to commit […]